Recipharm announces that it has this morning acquired 4,881,437 Consort Shares, representing 9.9 per cent. of the existing issued share capital of Consort Medical, at 1,010 pence per share and a further 118,563 Consort Shares, representing 0.2 per cent. of the existing issued share capital of Consort Medical at 1,000 pence per share.
Recipharm’s Offer remains open for acceptances until 1.00 p.m. (London time) tomorrow, 23 January 2020, and Consort Shareholders are encouraged to submit their acceptances without delay.
Unless otherwise stated, the terms used in this announcement have the same meanings as given to them in the Offer Document.
Source: Biospace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.